COPD: The Silent Killer No One Knows About

Main Category: COPD
Article Date: 08 Oct 2007 - 2:00 PST


What:

Science Press Breakfast to learn about COPD, the silent killer few know about, and the acronym that few can identify. Expert panel will discuss the latest epidemiology of this growing disease (expected to rank #3, after heart disease and cancer, by 2020); the most recent research; current screening techniques; and the future technologies for detection and treatment. Special discussion on research to identify the genetic markers of lung disease.

Sponsors:

- National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health:
"Learn More, Breathe Better" COPD Awareness Campaign
- New York City Department of Health and Mental Hygiene

Hosts:

- Dr. Antonio Gotto, Jr., Dean, Weill Cornell Medical College
- Dr. Andrew Schafer, Chairman, Department of Medicine at NewYork-Presbyterian/Weill Cornell
- Special Representative from NYC DOH, TB/Pulmonary Division

Who:

- Dr. James Kiley, Director of the Lung Diseases Division, National Heart, Lung, and Blood Institute
COPD: Overview and "Learn More, Breathe Better" Campaign

- Dr. Patricia Cassano, Associate Professor, Nutritional Epidemiology, Cornell University Epidemiology of COPD: Established and Novel Risk Factors

- Dr. Ronald Crystal, Chairman, Genetic Medicine and Chief, Pulmonary/Critical Care Medicine at NewYork-Presbyterian/Weill Cornell
New Paths of Discovery: Researching the Genetic Biomarkers of COPD

When:

Wednesday, October 10, 2007
Breakfast: 9:00 a.m.
Briefing: 9:30 a.m.
COPD Screening Event: 11:30 a.m.

Where:

NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Weill Greenberg Conference Center
1305 York Avenue (at E. 70th St), 2nd Floor

Ask About…the role of airborne and environmental pollutants in COPD; why screening and treatment of lung disease lag behind heart disease; whether 9/11 plays any role; why more women are dying than men; how COPD differs from asthma…

Hear About…the early research on finding genetic biomarkers for lung disease -- akin to the way markers (such as LDL/HDL) have been found for heart disease. Without these markers, the battle against lung disease will continue to remain decades behind heart disease. Please attend and help us break the trend!!

NewYork-Presbyterian Hospital

• Additional
• References
• Citations